Literature DB >> 25546787

Advances of intravenous immunoglobulin G in modulation of anti-fetal immunity in selected at-risk populations: science and therapeutics.

O B Christiansen1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25546787      PMCID： PMC4285516          DOI： 10.1111/cei.12536

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  23 in total

Review 1.  Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review.

Authors:  B Hutton; R Sharma; D Fergusson; A Tinmouth; P Hebert; J Jamieson; M Walker
Journal:  BJOG       Date:  2006-12-12       Impact factor: 6.531

2.  Maternal homozygocity for a 14 base pair insertion in exon 8 of the HLA-G gene and carriage of HLA class II alleles restricting HY immunity predispose to unexplained secondary recurrent miscarriage and low birth weight in children born to these patients.

Authors:  Ole B Christiansen; Astrid M Kolte; Mette Dahl; Elisabeth C Larsen; Rudi Steffensen; Henriette S Nielsen; Thomas V Hviid
Journal:  Hum Immunol       Date:  2012-04-23       Impact factor: 2.850

3.  Plasma TNF-α levels are higher in early pregnancy in patients with secondary compared with primary recurrent miscarriage.

Authors:  Zofia Maria Piosik; Yuri Goegebeur; Louise Klitkou; Rudi Steffensen; Ole Bjarne Christiansen
Journal:  Am J Reprod Immunol       Date:  2013-05-09       Impact factor: 3.886

4.  Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.

Authors:  Manuela Moraru; Javier Carbone; Diana Alecsandru; Marcela Castillo-Rama; Aurea García-Segovia; Juana Gil; Bárbara Alonso; Angel Aguarón; Rocío Ramos-Medina; Juan Martínez de María; Desamparados Oliver-Miñarro; Margarita Rodríguez-Mahou; Virginia Ortega; Pedro Caballero; Elena Meliá; Juan Vidal; Malena Cianchetta-Sivori; Carmen Esteban; Loreto Vargas-Henny; Jonathan Dale; Luis Ortiz-Quintana; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón
Journal:  Am J Reprod Immunol       Date:  2012-04-18       Impact factor: 3.886

5.  A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage.

Authors:  Ole B Christiansen; Bjørn Pedersen; Anni Rosgaard; Merete Husth
Journal:  Hum Reprod       Date:  2002-03       Impact factor: 6.918

6.  Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.

Authors:  Mary D Stephenson; William H Kutteh; Susan Purkiss; Cliff Librach; Patricia Schultz; Edwina Houlihan; Chuanhong Liao
Journal:  Hum Reprod       Date:  2010-07-15       Impact factor: 6.918

7.  A study of HLA-DR and -DQ alleles in 588 patients and 562 controls confirms that HLA-DRB1*03 is associated with recurrent miscarriage.

Authors:  C Kruse; R Steffensen; K Varming; O B Christiansen
Journal:  Hum Reprod       Date:  2004-04-07       Impact factor: 6.918

8.  Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy.

Authors:  Henriette Svarre Nielsen; Rudi Steffensen; Kim Varming; Astrid G S Van Halteren; Eric Spierings; Lars P Ryder; Els Goulmy; Ole Bjarne Christiansen
Journal:  Hum Mol Genet       Date:  2009-02-17       Impact factor: 6.150

9.  CD3-CD56+CD16+ natural killer cells and improvement of pregnancy outcome in IVF/ICSI failure after additional IVIG-treatment.

Authors:  Lothar Heilmann; Martin Schorsch; Thomas Hahn
Journal:  Am J Reprod Immunol       Date:  2010-01-08       Impact factor: 3.886

10.  Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G.

Authors:  Roumen G Roussev; Siu Chui Ng; Carolyn B Coulam
Journal:  Am J Reprod Immunol       Date:  2007-04       Impact factor: 3.886
View more
  1 in total

Review 1.  Current Understanding of Natural Antibodies and Exploring the Possibilities of Modulation Using Veterinary Models. A Review.

Authors:  G IJsbrand Reyneveld; Huub F J Savelkoul; Henk K Parmentier
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.